Portable Ultrasound Monitoring for Premature Infant Monitoring
(POCUS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if portable ultrasound devices can help nurses quickly monitor premature babies between 24 and 32 weeks of gestation. The trial compares two methods: continuous fetal monitoring (the usual method) and a handheld ultrasound device. Researchers seek pregnant women carrying a single baby within this gestational age range. Participants will help determine if the portable ultrasound method is faster and more efficient than the standard approach. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance monitoring techniques for premature babies.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that portable ultrasound devices are safe for premature infant monitoring?
Research has shown that handheld ultrasound devices used at the point of care are generally safe and non-invasive. Doctors commonly use these devices in emergency rooms and intensive care units to diagnose and treat patients more quickly. However, detailed information about their safety specifically for newborns remains limited.
Overall, portable ultrasound is considered safe, with no major side effects reported. This makes it a promising tool for monitoring babies without causing harm.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to enhance fetal monitoring for premature infants. Traditional methods like continuous fetal monitoring (cEFM) involve stationary machines that may not provide real-time flexibility. However, the trial's experimental method uses a Point of Care Handheld Ultrasound. This portable device allows nurses to quickly locate and monitor the fetal heart, potentially making the process faster and more adaptable in various settings. By combining this handheld technology with cEFM, the trial aims to improve the efficiency and effectiveness of fetal monitoring, offering a promising advance over current standard practices.
What evidence suggests that using portable ultrasound devices is effective for premature infant monitoring?
Research shows that Point of Care Handheld Ultrasound, one method studied in this trial, promises faster and more accurate monitoring. Studies indicate it effectively provides quick bedside images, especially useful in NICUs (Neonatal Intensive Care Units). This method helps nurses locate the baby's heart swiftly, speeding up the connection to monitoring devices. Evidence-based guidelines support its use for very sick newborns, suggesting it can enhance care. This approach is gaining popularity because it reduces wait times and improves monitoring accuracy, crucial for premature babies. Meanwhile, Continuous Fetal Monitoring, another method under study, remains a standard practice for fetal monitoring.34678
Are You a Good Fit for This Trial?
This trial is for pregnant women aged 18 to 50 with a single baby between 24 and 32 weeks of gestation. It's not suitable for those outside this pregnancy window, under age 18, if the fetus has a known lethal anomaly where monitoring was declined, or if they are incarcerated.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Nurses use handheld ultrasound devices to assist with applying continuous external fetal monitoring (cEFM) in early preterm pregnancies
Follow-up
Participants are monitored for the time to successful detection of fetal heart rate and any need for physician intervention
What Are the Treatments Tested in This Trial?
Interventions
- Continuous Fetal Monitoring
- Point of Care Handheld Ultrasound
Trial Overview
The study is examining whether nurses using handheld ultrasound devices can speed up the process of fetal monitoring on babies from ages of gestational weeks 24 to 32 compared to standard procedures.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
A nurse will turn on the Obix cEFM machine which will automatically register the patient in the Obix system and begin the timer which will be used to measure time to fetal monitoring. The patient will lay on the triage stretcher and a Butterfly ultrasound (Figure 1) probe will be used with a secure institutional Ipad by the triage nurse to identify the fetal position and location of the fetal heart. All images are deidentified and not stored since it will be a live real time aid to obtain a fetal heart tracing via cEFM. The cEFM will be placed on the maternal abdomen according to the imaging obtained by the ultrasound. Once fetal heart rate signal is obtained via cEFM, the patient's participation in the study ends.
A nurse will turn on the Obix cEFM machine which will automatically register the patient in the Obix system and begin the timer which will be used to measure time to fetal monitoring. The patient will lay on the triage stretcher and the continuous external fetal monitor doppler probe will be placed on the abdomen over the fetus, identified via Leopold maneuvers. Nurses will adjust the cEFM as needed until a full fetal heart rate signal is obtained. At this point the timer will be counted as the time to monitor. Once the fetal heart rate signal is obtained via cEFM, the patient's participation in the study ends.
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Medical Branch, Galveston
Lead Sponsor
Published Research Related to This Trial
Citations
Applications of Point-of-Care-Ultrasound in Neonatology
These studies could help determine how POCUS effectiveness varies among different neonatal populations, including preterm and full-term neonates ...
2.
publications.aap.org
publications.aap.org/pediatrics/article/150/6/e2022060053/190110/Use-of-Point-of-Care-Ultrasonography-in-the-NICUUse of Point-of-Care Ultrasonography in the NICU for ...
Point-of-care ultrasonography (POCUS) refers to the use of portable imaging performed by the provider clinician at the bedside for ...
Comparison of Six Handheld Ultrasound Devices by ...
Most importantly, the three highest ranking handhelds — Kosmos™, Lumify™, and Vscan Air™ — had more positive than negative comments, while ...
International evidence-based guidelines on Point of Care ...
Evidence-based guidelines for the use of POCUS in critically ill neonates and children are now available. They will be useful to optimise the use of POCUS.
5.
publications.aap.org
publications.aap.org/pediatrics/article/150/6/e2022060052/190109/Use-of-Point-of-Care-Ultrasonography-in-the-NICUUse of Point-of-Care Ultrasonography in the NICU for ...
This clinical report describes the current landscape of neonatal POCUS, outlines barriers for implementation, and provides a suggested educational framework.
Handheld Point-of-Care Ultrasound: Safety Considerations for ...
HPOCUS can be a powerful tool for expedited diagnosis and management guidance. However, there is limited data regarding patient safety and current regulatory ...
Portable Ultrasound Monitoring for Premature Infant ...
The available research suggests that point-of-care ultrasound (POCUS) is considered a safe and non-invasive tool widely used in emergency, intensive care, ...
Portable Point of Care Ultrasound (PPOCUS)
PPOCUS which involves the use of handheld, portable, affordable, easy-to-use ultrasound devices to perform point of care ultrasound (POCUS) is an emerging ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.